Cigna Corporation (CI) Position Held by John G Ullman & Associates Inc.

John G Ullman & Associates Inc. held its stake in shares of Cigna Corporation (NYSE:CI) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,400 shares of the health services provider’s stock at the end of the second quarter. John G Ullman & Associates Inc.’s holdings in Cigna Corporation were worth $402,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Guardian Life Insurance Co. of America boosted its stake in shares of Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after buying an additional 7 shares during the last quarter. Bronfman E.L. Rothschild L.P. boosted its stake in shares of Cigna Corporation by 1.1% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 2,112 shares of the health services provider’s stock worth $309,000 after buying an additional 22 shares during the last quarter. Boys Arnold & Co. Inc. boosted its stake in shares of Cigna Corporation by 1.8% in the first quarter. Boys Arnold & Co. Inc. now owns 1,833 shares of the health services provider’s stock worth $269,000 after buying an additional 33 shares during the last quarter. Winslow Evans & Crocker Inc. boosted its stake in shares of Cigna Corporation by 1.9% in the second quarter. Winslow Evans & Crocker Inc. now owns 1,814 shares of the health services provider’s stock worth $304,000 after buying an additional 34 shares during the last quarter. Finally, IFP Advisors Inc boosted its stake in shares of Cigna Corporation by 1.9% in the first quarter. IFP Advisors Inc now owns 2,180 shares of the health services provider’s stock worth $319,000 after buying an additional 41 shares during the last quarter. Hedge funds and other institutional investors own 87.61% of the company’s stock.

Cigna Corporation (NYSE CI) opened at 177.03 on Friday. The stock’s 50 day moving average is $173.66 and its 200-day moving average is $160.28. The company has a market cap of $44.57 billion, a P/E ratio of 20.43 and a beta of 0.46. Cigna Corporation has a 12-month low of $115.03 and a 12-month high of $181.00.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The firm had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. During the same period in the prior year, the firm posted $1.98 earnings per share. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. Analysts predict that Cigna Corporation will post $10.03 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Cigna Corporation (CI) Position Held by John G Ullman & Associates Inc.” was posted by BNB Daily and is the property of of BNB Daily. If you are reading this story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this story can be viewed at https://www.baseball-news-blog.com/2017/08/19/cigna-corporation-ci-position-maintained-by-john-g-ullman-associates-inc-updated-updated.html.

A number of brokerages recently weighed in on CI. UBS AG restated a “buy” rating and set a $186.00 target price (up from $181.00) on shares of Cigna Corporation in a report on Monday, June 5th. Jefferies Group LLC restated a “buy” rating and set a $183.00 target price on shares of Cigna Corporation in a report on Thursday, June 8th. Deutsche Bank AG raised their target price on shares of Cigna Corporation from $175.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, July 13th. BidaskClub upgraded shares of Cigna Corporation from a “buy” rating to a “strong-buy” rating in a report on Friday. Finally, Royal Bank Of Canada raised their price objective on shares of Cigna Corporation from $172.00 to $177.00 and gave the stock an “outperform” rating in a research note on Monday, May 15th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $180.44.

In other Cigna Corporation news, EVP Lisa R. Bacus sold 11,455 shares of the company’s stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $161.57, for a total transaction of $1,850,784.35. Following the sale, the executive vice president now directly owns 24,753 shares of the company’s stock, valued at $3,999,342.21. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Michael W. Triplett sold 1,439 shares of the company’s stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $166.89, for a total transaction of $240,154.71. Following the sale, the insider now directly owns 26,199 shares in the company, valued at $4,372,351.11. The disclosure for this sale can be found here. Insiders have sold 243,463 shares of company stock worth $41,678,984 over the last ninety days. Insiders own 1.30% of the company’s stock.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply